[go: up one dir, main page]

GB0625842D0 - Indolizine derivatives - Google Patents

Indolizine derivatives

Info

Publication number
GB0625842D0
GB0625842D0 GBGB0625842.0A GB0625842A GB0625842D0 GB 0625842 D0 GB0625842 D0 GB 0625842D0 GB 0625842 A GB0625842 A GB 0625842A GB 0625842 D0 GB0625842 D0 GB 0625842D0
Authority
GB
United Kingdom
Prior art keywords
indolizine derivatives
indolizine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0625842.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Priority to GBGB0625842.0A priority Critical patent/GB0625842D0/en
Publication of GB0625842D0 publication Critical patent/GB0625842D0/en
Priority to CNA2007800514253A priority patent/CN101605789A/en
Priority to US12/520,004 priority patent/US20100093751A1/en
Priority to PCT/GB2007/004789 priority patent/WO2008078069A1/en
Priority to JP2009542192A priority patent/JP2010513432A/en
Priority to EP07848531A priority patent/EP2121686A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB0625842.0A 2006-12-22 2006-12-22 Indolizine derivatives Ceased GB0625842D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0625842.0A GB0625842D0 (en) 2006-12-22 2006-12-22 Indolizine derivatives
CNA2007800514253A CN101605789A (en) 2006-12-22 2007-12-13 Indolizine acetic acid and its therapeutic use as a ligand for the CRTH2 receptor
US12/520,004 US20100093751A1 (en) 2006-12-22 2007-12-13 Indolizineacetic Acids and Their Therapeutic Use as Ligands of the CRTH2 Receptor
PCT/GB2007/004789 WO2008078069A1 (en) 2006-12-22 2007-12-13 Indolizineacetic acids and their therapeutic use as ligands of the crth2 receptor
JP2009542192A JP2010513432A (en) 2006-12-22 2007-12-13 Indolizine acetic acid and its therapeutic use as a ligand for CRTH2 receptor
EP07848531A EP2121686A1 (en) 2006-12-22 2007-12-13 Indolizineacetic acids and their therapeutic use as ligands of the crth2 receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0625842.0A GB0625842D0 (en) 2006-12-22 2006-12-22 Indolizine derivatives

Publications (1)

Publication Number Publication Date
GB0625842D0 true GB0625842D0 (en) 2007-02-07

Family

ID=37758997

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0625842.0A Ceased GB0625842D0 (en) 2006-12-22 2006-12-22 Indolizine derivatives

Country Status (6)

Country Link
US (1) US20100093751A1 (en)
EP (1) EP2121686A1 (en)
JP (1) JP2010513432A (en)
CN (1) CN101605789A (en)
GB (1) GB0625842D0 (en)
WO (1) WO2008078069A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0719521D0 (en) * 2007-10-05 2007-11-14 Argenta Discovery Ltd Compounds
MX2012010820A (en) 2010-03-22 2012-10-10 Actelion Pharmaceuticals Ltd DERIVATIVES OF 3- (HETEROARIL-AMINO) -1, 2, 3, 4-TETRAHIDRO-9H-CARBAZO L AND ITS USE AS MODULATORS OF THE PROSTAGLANDINE RECEIVER D2.
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
WO2012140612A1 (en) 2011-04-14 2012-10-18 Actelion Pharmaceuticals Ltd 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
EP2545964A1 (en) 2011-07-13 2013-01-16 Phenex Pharmaceuticals AG Novel FXR (NR1H4) binding and activity modulating compounds
CN104114169A (en) 2011-12-16 2014-10-22 阿托佩斯治疗有限公司 Combination of CRTH2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
UA117780C2 (en) 2014-03-17 2018-09-25 Ідорсія Фармасьютікалз Лтд AZAINDOLACETIC ACID DERIVATIVES AND THEIR APPLICATIONS AS MODULATORS OF PROSTAGLANDIN D2 RECEPTORS
RU2016140708A (en) 2014-03-18 2018-04-18 Идорсиа Фармасьютиклз Лтд Acetic acid derivatives of azaindole and their use as modulators of the prostaglandin receptor D2
UA123156C2 (en) 2015-09-15 2021-02-24 Ідорсія Фармасьютікалз Лтд Crystalline forms
CA3252823A1 (en) 2016-06-13 2025-02-25 Gilead Sciences Inc Fxr (nr1h4) modulating compounds
SI3730487T1 (en) 2016-06-13 2022-08-31 Gilead Sciences, Inc. Azetidine derivatives as fxr (nr1h4) modulators
JP6906626B2 (en) 2017-03-28 2021-07-21 ギリアード サイエンシーズ， インコーポレイテッド Therapeutic combination for treating liver disease
CN109721530A (en) * 2017-10-31 2019-05-07 成都博腾药业有限公司 A method of preparing the fluoro- 2- pyridine sulfonyl chloride of 6-
US11225473B2 (en) 2019-01-15 2022-01-18 Gilead Sciences, Inc. FXR (NR1H4) modulating compounds
EP3927683A1 (en) 2019-02-19 2021-12-29 Gilead Sciences, Inc. Solid forms of fxr agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0512944D0 (en) * 2005-06-24 2005-08-03 Argenta Discovery Ltd Indolizine compounds
EA200970590A1 (en) * 2006-12-21 2009-12-30 Арджента Дискавери Лимитед CRTH2 ANTAGONISTS

Also Published As

Publication number Publication date
US20100093751A1 (en) 2010-04-15
CN101605789A (en) 2009-12-16
JP2010513432A (en) 2010-04-30
WO2008078069A1 (en) 2008-07-03
EP2121686A1 (en) 2009-11-25

Similar Documents

Publication Publication Date Title
IL194367A0 (en) Dihydropyrazolopyrimidinone derivatives
IL196543A0 (en) Pyridizinone derivatives
IL193641A0 (en) Spiroindolinone derivatives
IL195013A0 (en) Pyridopyrimidinone derivatives
IL198319A0 (en) Spiroindolinone derivatives
IL195422A0 (en) 2-pyrazinecarboxamide derivatives
ZA200806809B (en) Pyridine-2-carboxamide derivatives
EP2009005A4 (en) Azolecarboxamide derivative
IL192401A0 (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
IL196364A0 (en) Aminoindazolylurea derivatives
IL198059A0 (en) 2-aminocarbonyl-pyridine derivatives
GB0702259D0 (en) 7-azaindole derivatives
IL193211A0 (en) Indazole-heteroaryl derivatives
ZA200904028B (en) 5-Hydroxymethyl-oxazolidin-2-one derivatives
IL197152A0 (en) 5-phenyl-nicotinamide derivatives
ZA200903175B (en) Spiro-piperidine derivatives
GB0625842D0 (en) Indolizine derivatives
EP2133347A4 (en) 1-biarylazetidinone derivatives
GB0702265D0 (en) 7-Azaindole derivatives
ZA200807460B (en) Spiroindolinone derivatives
TWI339663B (en) Spiro-piperidine derivatives
IL197239A0 (en) Phenyloxyaniline derivatives
GB0610019D0 (en) Benzotriazepinone derivatives
GB0610018D0 (en) Benzotriazepinone derivatives
IL198973A0 (en) Sulfamatobenzothiophene derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)